Drug Utilization Review

The Idaho Drug Utilization Review (DUR) Program was established in 1993 to fulfill specific requirements of the Omnibus Budget Reconciliation Act of 1990 (OBRA 90) as a contingency for the Idaho Department of Health and Welfare to receive federal funding. The DUR program uses a structured process to review claims data and interpret patterns of drug use in relation to predetermined criteria. The goals of the program are to reduce potentially inappropriate prescribing and dispensing of medications, enhance the counseling of patients, and reduce growth in expenditures for drugs.

Board members

  • Christopher Partridge, MD (Meridian, serving since 2020)
  • Dawn Berheim, PharmD (Meridian, serving since 2020)
  • Magni Hamso, MD (Boise, serving since 2020)
  • Perry Brown, MD (Physician, Boise)
  • Sabrina Allen, PharmD (Boise, serving since 2020)
  • Tami Eide, PharmD (Boise, serving since 2002)
  • Walter L Fitzgerald, Jr., BPharm, MS, JD, Dean (Pocatello, serving since 2021)
  • Wayne Baures, RPh (Spirit Lake, serving since 2012)

2024 Meeting Dates

January 18, 2024


Call-In Information

April 18, 2024Agenda - Updated
July 18, 2024 
October 17, 2024 


2023 Meeting Dates

January 19, 2023

January Call-In Information

January Meeting Information (including agenda)

April 20, 2023

April Call-In Information

April Meeting Information (including agenda)

July 20, 2023Cancelled
October 19, 2023October Call-in Information
October Meeting Information (including agenda)


Carol Perkins, PharmD., BCPS
Prime Therapeutics